<?xml version="1.0" encoding="UTF-8"?>
<document id="28213878">
	<sentence id="s1" text="Norepinephrine transporter (NET) transfection leads to significant uptake of iodine-131-labeled metaiodobenzylguanidine (lsup>131</sup>I-MIBG) in non-neuroendocrine tumors.">
		<entity id="s1.e1" charOffset="28-31"
			type="GENE" text="NET" ontology_id="2004"/>
		<entity id="s1.e2" charOffset="165-171"
			type="HP" text="tumors" ontology_id="HP_0002664"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
	</sentence>
	<sentence id="s2" text="We evaluated the uptake and efflux of lsup>131</sup>I-MIBG both in vitro and in vivo in mice bearing transfected tumors.">
		<entity id="s2.e1" charOffset="88-92"
			type="GENE" text="mice" ontology_id="23581"/>
		<entity id="s2.e2" charOffset="113-119"
			type="HP" text="tumors" ontology_id="HP_0002664"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
	</sentence>
	<sentence id="s3" text="In vivo experiments were performed in nude mice bearing transfected tumors; results revealed that NET-VMAT2-coexpressing tumors had longer lsup>131</sup>I-MIBG retention time than NET-expressing tumors.">
		<entity id="s3.e1" charOffset="10-13"
			type="GENE" text="per" ontology_id="93210"/>
		<entity id="s3.e2" charOffset="38-42"
			type="GENE" text="nude" ontology_id="54820"/>
		<entity id="s3.e3" charOffset="43-47"
			type="GENE" text="mice" ontology_id="23581"/>
		<entity id="s3.e4" charOffset="68-74"
			type="HP" text="tumors" ontology_id="HP_0002664"/>
		<entity id="s3.e5" charOffset="98-101"
			type="GENE" text="NET" ontology_id="2004"/>
		<entity id="s3.e6" charOffset="102-107"
			type="GENE" text="VMAT2" ontology_id="6571"/>
		<pair id="s3.p1" e1="s3.e4"
		    e2="s3.e5" pgr="false"/>
		<pair id="s3.p2" e1="s3.e6"
		    e2="s3.e6" pgr="false"/>
		<pair id="s3.p3" e1="s3.e3"
		    e2="s3.e4" pgr="false"/>
		<pair id="s3.p4" e1="s3.e2"
		    e2="s3.e4" pgr="false"/>
		<pair id="s3.p5" e1="s3.e1"
		    e2="s3.e4" pgr="false"/>
	</sentence>
	<sentence id="s4" text="Meanwhile, NET-VMAT2-coexpressing and NET-expressing tumors displayed 0.54% and 0.19%, respectively, of the injected dose per gram of tissue 24 h after lsup>131</sup>I-MIBG administration.">
		<entity id="s4.e1" charOffset="11-14"
			type="GENE" text="NET" ontology_id="2004"/>
		<entity id="s4.e2" charOffset="15-20"
			type="GENE" text="VMAT2" ontology_id="6571"/>
		<entity id="s4.e3" charOffset="53-59"
			type="HP" text="tumors" ontology_id="HP_0002664"/>
		<entity id="s4.e4" charOffset="122-125"
			type="GENE" text="per" ontology_id="93210"/>
		<pair id="s4.p1" e1="s4.e1"
		    e2="s4.e3" pgr="false"/>
		<pair id="s4.p2" e1="s4.e2"
		    e2="s4.e3" pgr="false"/>
		<pair id="s4.p3" e1="s4.e3"
		    e2="s4.e4" pgr="false"/>
	</sentence>
</document>
